Clinical Trials

Neuroblastoma

NCT06501391 2024-08-28

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis

Phase 2 Recruiting

54 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03620032 2023-12-06

DIPG

54 enrolled

Diffuse Intrinsic Pontine Glioma

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

63 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01567202 2020-09-09

Study of DC Vaccination Against Glioblastoma

100 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT04450160 2020-06-29

AEO

80 enrolled

Glioblastoma, Seizures

NCT00798811 2020-03-19

High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors

100 enrolled

Brain Neoplasms

NCT00238277 2018-06-27

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Phase 2 Terminated

15 enrolled

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT02425072 2017-08-10

NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer

Phase 2 Withdrawn

CNSThoracic

Brain Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT00003996 2016-12-07

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

93 enrolled

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00274755 2014-05-20

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas

Phase 2 Completed

250 enrolled

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT01172912 2013-08-12

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

47 enrolled

CNSGenitourinary

Testicular Germ Cell Tumor, Testicular Neoplasms, Central Nervous System Neoplasms

NCT00389766 2013-07-10

High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma

Phase 2 Withdrawn

Neuroblastoma

NCT00002639 2013-06-21

Suramin in Treating Patients With Recurrent Primary Brain Tumors

Phase 2 Completed